InvestorsHub Logo
Followers 1
Posts 131
Boards Moderated 0
Alias Born 09/12/2017

Re: None

Wednesday, 03/20/2019 9:57:31 AM

Wednesday, March 20, 2019 9:57:31 AM

Post# of 278
Waking up from a long winter hibernation......and the links below are two of their secondary products. Very positive advancements on both. Future looks bright, but patience is required (2-3 quarters). Everything they are doing seems to be on the right track now (after the delay in CarpX approval) with real paths for approval for both CarpX and EsoCheck. My only concern is they may be running a little low on cash but hopefully they will address that at next CC and not have to dilute. With market cap at $29M today (they do have 17M warrants out with a strike of $1.60 expiring 2024) and total potential market of $3B (with just CarpX and EsoCheck), reward to risk is very outsized here with multiple shots on goal this year. Very long and adding. GL

https://seekingalpha.com/pr/17449710-pavmed-announces-nextflo-breakthrough

https://seekingalpha.com/pr/17442613-pavmed-announces-portio-breakthrough

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PAVM News